{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:11:13Z","timestamp":1790683873445,"version":"4.1.0"},"reference-count":21,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,11,28]]},"DOI":"10.3233\/jad-170078","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T11:22:10Z","timestamp":1510658530000},"page":"295-307","source":"Crossref","is-referenced-by-count":12,"title":["Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"61","author":[{"given":"Noam Y.","family":"Kirson","sequence":"first","affiliation":[{"name":"Analysis Group, Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Scott Andrews","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvi","family":"Desai","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"King","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Schonfeld","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard G.","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Ball","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Kahle-Wrobleski","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170078_ref1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer\u2019s disease facts and figures","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170078_ref2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/0891988705281869","article-title":"Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression","volume":"18","author":"Mortimer","year":"2005","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-170078_ref3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170078_ref4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer\u2019s disease","volume":"65","author":"De-Paula","year":"2012","journal-title":"Subcell Biochem"},{"key":"10.3233\/JAD-170078_ref5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3233\/JAD-150692","article-title":"Timely diagnosis for Alzheimer\u2019s disease: A literature review on benefits and challenges","volume":"49","author":"Dubois","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170078_ref6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cger.2013.07.003","article-title":"Classification and epidemiology of MCI","volume":"29","author":"Roberts","year":"2013","journal-title":"Clin Geriatr Med"},{"key":"10.3233\/JAD-170078_ref7","doi-asserted-by":"crossref","first-page":"b158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"10.3233\/JAD-170078_ref8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1440-1789.2005.00605.x","article-title":"Overlap between neurodegenerative disorders","volume":"25","author":"Armstrong","year":"2005","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-170078_ref9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1368-504X.2005.00480.x","article-title":"Inequalities in dementia care across Europe: Key findings of the Facing Dementia Survey","author":"Bond","year":"2005","journal-title":"Int J Clin Pract Suppl"},{"key":"10.3233\/JAD-170078_ref10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","article-title":"Missed and delayed diagnosis of dementia in primary care: Prevalence and contributing factors","volume":"23","author":"Bradford","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-170078_ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-14-101","article-title":"Early intervention in Alzheimer\u2019s disease: A health economic study of the effects of diagnostic timing","volume":"14","author":"Barnett","year":"2014","journal-title":"BMC Neurology"},{"key":"10.3233\/JAD-170078_ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jalz.2009.01.028","article-title":"Early identification and treatment of Alzheimer\u2019s disease: Social and fiscal outcomes","volume":"5","author":"Weimer","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170078_ref13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jalz.2013.01.015","article-title":"Implications of early treatment among Medicaid patients with Alzheimer\u2019s disease","volume":"10","author":"Geldmacher","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170078_ref14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170078_ref17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archneur.56.7.857","article-title":"Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer\u2019s Disease","volume":"56","author":"Clark","year":"1999","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170078_ref18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000017201","article-title":"Key methodological features of randomized controlled trials of Alzheimer\u2019s disease therapy. Minimal clinically important difference, sample size and trial duration","volume":"10","author":"Burback","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-170078_ref19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-170078_ref20","doi-asserted-by":"crossref","first-page":"P155","DOI":"10.1016\/j.jalz.2015.07.085","article-title":"Identifying clinically relevant milestone decline in predementia Alzheimer\u2019s disease","volume":"11","author":"Lasser","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170078_ref21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer\u2019s disease patients","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170078_ref22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-170078_ref23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:11Z","timestamp":1777370711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":21,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-170078","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}